Extended-spectrum β-lactamase infections during pregnancy: a growing threat

American Journal of Obstetrics and Gynecology
Catherine S Eppes, Steven L Clark

Abstract

Extended-spectrum β-lactamases (ESBLs) are rapidly evolving plasmid transferrable enzymes that confer unique patterns of antibiotic resistance on various bacterial species. Such organisms pose special challenges to laboratory identification, as well as antibiotic selection, administration, and follow-up. Although such infections are increasingly common in the obstetric population, issues surrounding ESBLs are not widely recognized by practicing obstetricians, and controversies exist regarding diagnosis and management. This article provides the practitioner with a summary of clinically pertinent information that will assist in the proper care of pregnant patients with ESBL infection.

References

Jan 7, 2000·Infection·E E StobberinghJ H van Zeijl
Dec 26, 2006·International Journal of Antimicrobial Agents·Husnu PullukcuSercan Ulusoy
Jul 15, 2009·The Journal of Hospital Infection·M E Falagas, D E Karageorgopoulos
Oct 16, 2012·International Journal of Antimicrobial Agents·Meltem Isikgoz TasbakanSercan Ulusoy
Aug 7, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marya D Zilberberg, Andrew F Shorr

❮ Previous
Next ❯

Citations

Jan 25, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mariam M YoussefNoha A Hassuna
Nov 15, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Nouf AbutheraaAlexander B Mullen
Jul 3, 2021·Microorganisms·Lital Ashtamkar MatokAvi Peretz
Jul 9, 2021·Obstetrics and Gynecology·Andrea ShieldsTorre Halscott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.